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Abstract
Background: The Cancer Rehabilitation Evaluation System (CARES) is a quality of life (QOL) and needs assessment
instrument of US origin that was developed in the 90’s. Since November 2012 the copyright and user fee were
abolished and the instrument became publicly available the present study aims to reinvestigate the psychometric
properties of the CARES for the Flemish population in Belgium.
Methods: The CARES was translated into Flemish following a translation-back translation process. A sample of 192
cancer patients completed the CARES, concurrent measures, and questions on socio-demographic and medical
data. Participants were asked to complete the CARES a second time 1 week later, followed by some questions on
their experiences with the instrument. Internal consistency, test-retest reliability, content validity, construct validity,
concurrent validity and feasibility of the CARES were subsequently assessed.
Results: The Flemish CARES version demonstrated excellent reliability with high internal consistency (range .87–.96)
and test-retest ratings (range .70–.91) for all summary scales. Factor analysis replicated the original factor solution of
five higher order factors with factor loadings of .325–.851. Correlations with other instruments ranging from |.43|–|.
75| confirmed concurrent validity. Feasibility was indicated by the low number of missing items (mean 2.3; SD 5.0)
and positive feedback of participants on the instrument.
Conclusions: The Flemish CARES has strong psychometric properties and can as such be a valid tool to assess
cancer patients’ QOL and needs in research, for example in international comparisons. The positive feedback of
participants on the CARES support the usefulness of this tool for systematic assessment of cancer patients’ well-
being and care needs in clinical practice.
Trial registration: ClinicalTrials.gov: NCT02282696 (July 16, 2014).
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Background
Cancer is a disease with a huge impact on patients and
their relatives, going far beyond the physical aspects.
Together with the rise of more successful therapeutic
approaches and the increased life expectancy, the psy-
chological and social aspects of care receive more atten-
tion as part of a holistic view of health care. Health care,
and certainly cancer care, therefore requires a more inte-
grated approach as a response to the fragmented delivery
of health and social services [1]. Together with more
integration, health is moving towards a more patient-
centered approach. This is a process evolution as
patient-centered care is an important dimension of qual-
ity of care [2]. Individualized, more integrated care plans
and clinical care pathways are developed to improve out-
comes for cancer patients, with an increasing emphasis
on quality of life (QOL) [3].
To integrate the psychosocial approach into cancer
care, the implementation of routine psychosocial screen-
ing and needs assessment is recommended by inter-
national cancer systems and in guidelines [4–9].
However, not all patients with a positive screen for dis-
tress or decreased QOL are interested in professional
support [10]. In some cases programs involving system-
atic or routine screening for distress lead to a consider-
able number of unaccepted referrals [11, 12]. In contrast
to QOL or distress screening, needs assessment not only
focuses on identifying patients’ unresolved concerns and
problems, but furthermore explores whether or not
there is a desire extra help [13]. This not only gives guid-
ance from the patients’ perspective for more integrated
and holistic care plans, but also allows for the more
effective and efficient use of resources. [10].
The Cancer Rehabilitation Evaluation System (CARES)
is a self-administered QOL and needs assessment instru-
ment that can be used for research or clinical purposes
[14–20]. The instrument covers a broad range of topics
relevant to the QOL disruption many cancer patients ex-
perience. The CARES consists of 139 items meant to re-
flect the multidimensional burden of cancer and its
treatment can cause to patients and their relatives. The
items can be scored broadly using the six summary
scales medical interaction, physical, psychosocial, marital
and sexual wellbeing and miscellaneous items; or in a
more detailed manner grouped under 31 subscales.
However, not all items apply to all patients and therefore
patients can complete a minimum of 93 items or a
maximum of 132 items. Patients can rate each item,
formulated as problem statement, on a five-point scale,
zero representing “not at all” (no problem) and four
representing “very much” (severe problem). For every
applicable problem statement patients are asked to
answer the question “Do you want help?” by ticking the
box ‘yes’ or ‘no’.
The psychometric robustness of the CARES and its’
earlier development versions called the Cancer Inventory
of Problem Situations (CIPS) are well documented and
positively evaluated [17, 18]. With high Crohnbachs
alpha’s (α = 0.87–0.94) and high test-retest correlations
(r = 0.84–0.95) for the summary scales and CARES total
the instrument demonstrates excellent reliability. The
validity of the CARES was also rigorously tested. Results
from post-administration interviews supported the con-
tent validity of the instrument [18, 21]. An extensive
evaluation of concurrent validity was conducted with the
Symptom Checklist-90 (SCL-90) [22], Dyadic Adjust-
ment Scale (DAS) [23], Karnofsky Performance status
Scale (KPS) [24, 25] and a visual analogue scale [26] for
QOL before and after cancer, resulting in moderate to
high correlations. In two studies investigating the feasi-
bility of the CARES for patients, the participants on
average needed 18 to 20 min to complete the CARES.
The majority of them thought the questionnaire
reflected relevant day-to-day problems of cancer pa-
tients; they understood the instructions well and found
questions easy to understand and not offensive [18].
Despite this good quality the widespread use of the
CARES and it’s short form was limited by copyright and
a user fee that the developers chose to impose. Since
November 2012 this is no longer the case [27].
Due to the combination of feasibility for patients, psy-
chometrical robustness and the wide representation of
life domains that can be disrupted by a cancer diagnosis
and the side effects associated with treatment, the
CARES was chosen for further research on QOL and
care needs in Belgium. However, time perspective,
culture and language are important for the ecological di-
mension and validity of an instrument [28]. Careful
translation and validation of an instrument are extremely
important for the data to be valid [29, 30]. Conse-
quently, a validation study on the CARES was con-
ducted in the Flemish-speaking part of Belgium. The
thorough validation-exercise is described in this article.
Methods
The protocol of this study, including a priori hypotheses
and criteria, is described in detail in a previous publica-
tion [31]. The procedures used the general principles of
scale development according to classical test theory.
Participants
There are no general criteria for the sample size in a val-
idation study, but a sample size of at least 50–100 is
generally recommended [32]. Sample sizes in the valid-
ation research of the original CARES varied for each
psychometric quality from 22 to 1047 [18]. In this valid-
ation study of the CARES, the objective was set to
include at least 150 participants.
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A heterogeneous sample of cancer patients was re-
cruited in several departments of four Flemish hospitals
from March 2014 to February 2015. Non-palliative can-
cer patients aged between 25 and 60 years with a pri-
mary diagnosis of Stage I, II or III cancer [33], were
included. The age restriction was chosen in the belief
that these adult cancer patients have a psychosocial con-
text which is clearly different from that of younger and
older patients by means of significant relationships with
children, partners, parents and the work context. There
were no exclusion criteria with regards to sex, perform-
ance status or topology of the cancer. Patients were ex-
cluded from the sample if they lacked basic proficiency
in Dutch, had cognitive problems or a history of major
neurological disease.. Patients signed an informed con-
sent form before participation.
Questionnaires
Participants had to complete two questionnaire bundles,
within an interval of 1 week.
Data collected with the first questionnaire bundle in-
cluded socio-demographic characteristics, medical charac-
teristics, the CARES and seven concurrent instruments to
assess concurrent validity.
Flemish CARES version
The Flemish CARES version was produced through a
forward-backward translation process with two sworn
translators and an expert group.
In the ongoing study missing response categories for
items 18 and 80 in the CARES were noticed, causing
structural (non-random) missing answers (55.7 % of the
analyzed questionnaires). A second and corrected ver-
sion was printed and replaced the first (44.3 % of the an-
alyzed questionnaires). To avoid possible bias, items 18
and 80 were excluded from analysis.
Karnofsky Performance status Scale (KPS) [24, 25, 34]:
The KPS is an 11-point scale to evaluate the physical
and daily functioning of a patient, ranging from 0 (com-
pletely dependent, not able to care for oneself ) to 100
(fully active, not dependent and capable of normal activ-
ity without limitations).
Hospital Anxiety and Depression Scale (HADS) [35, 36]:
The HADS was developed to identify symptoms of
anxiety and depression in medically ill patients. The
questionnaire contains 14 items with four response cat-
egories, ranging from 0–3. Higher scores on the two
subscales (each consisting of 7 items) indicate a higher
level of anxiety or depression and the total score of the
HADS (score-ranges from 0–42) can be used as a global
measure of psychological distress [37].
Social Support List-Interactions and Discrepancies
(SSL-I and-D) [38–40]: The SSL is a questionnaire with
75 items, 41 on experienced social interaction and 34 on
experienced social discrepancies. In the first part of the
questionnaire participants indicate how frequently cer-
tain social interactions occur on a 4-point Likert scale
from 1 (‘seldom or never’) to 4 (‘very often’), with higher
scores representing higher levels of social support. A
second part of the SLL indicates the social discrepancies
participants experience ranging from 1 (‘I would like it
to happen more often’) to 4 (‘it happens too often’).
Higher scores on the SSL-D indicate a greater lack of so-
cial support.
Maudsley Marital Questionnaire (MMQ) [41–43]: The
MMQ contains three scales exploring Marital (10 items),
Sexual (five items) and General Life (five items) adjust-
ment. The items of the MMQ are scored on a 9-point
Likert scale (ranging from 0 to 8). The wording of re-
sponse categories differs for each item depending on the
nature of the question.
European Organisation of Research and Treatment for
Cancer Quality of Life Questionnaire Core 30 (EORTC-
QLQ-C30) [44]: The EORTC QLQ-C30 is a cancer-
targeted quality of life instrument, incorporating five func-
tional scales (physical, role, cognitive, emotional and
social) and three symptom scales (fatigue, pain and nausea,
and vomiting). Items are scored on a 4-point Likert scale
from 1 (‘not at all’) to 4 (‘very much’). The last two items
on global health and quality-of-life have an 8-point Likert
scale, ranging from 1 (‘very poor’) to 7 (‘excellent’).
Distress Thermometer (DT) together with a Problem
List (PL) [45–47]: Patients are asked to rate their overall
distress on a visual analogue scale (presented as a therm-
ometer) from 0 (‘no distress’) to 10 (‘extreme distress’).
The DT is accompanied by a Problem List, which in-
cludes 35 items that address 5 life domains (practical,
family/social, emotional, spiritual, and physical problems).
Participants indicate if the stated problems apply to them.
At the end of the survey participants are asked if they
want to talk to a professional about their problems.
Care Needs Questionnaire [48]: The Care Needs Ques-
tionnaire was developed by Pauwels and Van Hoof to as-
sess the care needs of cancer patients regarding specific
themes during reintegration: physical functioning, psy-
chological functioning, self and body image, sexuality,
relationship with partner, relationship with others and
work and social security related aspects. For each theme,
participants are asked whether they wish to receive
information or support, how they prefer to receive in-
formation and support, and to what extent this need
already has been met. Each of the questions are an-
swered on a 3-and 4-point Likert scale with different
wording.
The second questionnaire bundle, filled in a week after
the first one, contained the CARES and supplementary
questions on patients’ experiences with the CARES in
relation to the importance and breadth of issues
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assessed, length of time to complete, and format of sur-
vey administration.
Study procedure
Eligible patients were selected by the medical team ac-
cording to the inclusion and exclusion criteria [49]. On
the basis of team organization and time availability, two
alternative procedures to invite patients to participate in
the study were used (Fig. 1).
In the ‘face-to-face procedure’, a member of the
medical team explained the study briefly and invited
the patient to participate. If the patient agreed, he/she
immediately received a study package with the in-
formed consent form, a ‘what to do’-scheme, the first
questionnaire bundle and a stamped and addressed
envelope to return the questionnaire.
In the ‘post procedure’, eligible patients got sent an
identical study package by post, plus a letter explaining
the study. One week later participants had to complete
the second questionnaire bundle and send it back in an-
other stamped and addressed envelope provided.
If the questionnaire was not sent back, the participants
recruited via the face-to-face procedures were contacted
by a team member. Participants invited through the post
procedure were sent a reminder and second question-
naire package after 1 month. The researcher contacted
participants by phone or by e-mail when returned ques-
tionnaires had a large number of missing responses or if
the second questionnaire was not received in the ex-
pected timeframe. Since ethical standards limit the num-
ber of participant contacts, there was a maximum of two
attempts to contact a participant.
Fig. 1 Study procedure
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Data analysis
The Statistical Package for Social Sciences (SPSS;
Chicago, IL) version 22.0 was used for statistical analyses
of the data.
Descriptive statistics were used to analyze socio-
demographic and medical data, as well as the data gath-
ered with the supplementary questions from the second
questionnaire bundle.
The reliability of the CARES was explored by the in-
ternal consistency of summary scales, with the aim to
find a Cohen’s Alpha of at least .70 [50, 51]. Test-retest
reliability was investigated by computing Spearman’s rho
correlations between the summary scale scores and
total-CARES scores of the first and second CARES
administration, requiring a correlation ≥ .70 [50, 52].
Principal component analysis (PCA) and inter cor-
relations of summary scales were computed to evalu-
ate construct validity. Due to the complexity of the
CARES, number of items and items only applicable
for a subgroup of the sample, one general factor
analysis on all the individual items was not possible
in this small sample. PCA with varimax rotation was
used in two subsequent analyses to assess the under-
lying factor pattern of the Flemish CARES. A first
PCA was carried out on the individual items of the
five summary scales to explore the CARES subscales.
A higher order (second-order) factor analysis on the
26 subscales was conducted to explore the five sum-
mary scales. As in previous CARES-research items
and subscales with a factor loading higher than .30
were seen as loading on a factor [17, 18].
Spearman’s rho correlations were computed to evaluate
concurrent validity of the CARES global score and the
summary scales with the seven concurrent instruments.
Correlations were judged low, moderate and high, when
their absolute values were respectively < .30, from .30–.50
and ≥ .50 [53].
Results
Sample characteristics
With 197 of the 325 invited patients returning com-
pleted questionnaires the response rate was 61 %. Of
these, 85 % (168/197) of the respondents returned both
the first and second questionnaire. After exclusion of
participants due to incorrect recruitment according to
the age (n = 4) and language-criterion (n = 1), a large
number of uncompleted questions (n = 2), a missing first
questionnaire (n = 2), anonymous returned questionnaire
(n = 1) or return outside the time interval of data inclu-
sion (n = 11); data of 176 eligible patients (54 % of the
invited patients) was available for analysis.
The mean age of participants was 50.5 years (range
30–60); 30.7 % were men and the vast majority were in
a significant relationship (86.9 %) and had children
(median: 2, range: 1–4). These and further socio-
demographic characteristics are displayed in Table 1.
The sample was characterized by a wide variation in
cancer diagnoses: respectively, breast (55.7 %), colorectal
(11.9 %), prostate (6.3 %), head-neck (4 %), testes
(2.8 %), lung (1.7 %), malign melanoma (1.7 %), brain
(1.7 %), esophagus (1.7 %), liver-gall-bladder (1.1 %), cer-
vix (1.1 %), uterus body (1.1 %), ovarian (1.1 %), kidney
(1.1 %), bladder (0.6 %), thyroid (0.6 %), stomach (0.6 %)
and bone cancer (0.6 %). Further medical data are shown
in Table 1.
Age, type and date of diagnosis and treatment (s) of
non-participants were collected anonymously to explore
the representativeness of the research sample (Table 1).
As compared with participants, the group of non-
responders was heterogeneous with respect to cancer
diagnosis: within 16 different types of diagnoses, the four
most common were: breast (34.4 %), colorectal (12.3 %),
malign melanoma (9.8 %) and prostate cancer (5.7 %).
Feasibility
CARES item characteristics
The mean number of missing answers on the QOL-
items in participants’ CARES completion was 2.3 (SD
5.0). Telephone follow-up with participants revealed that
missing answers were mainly due to the accidental skip-
ping of items or participants’ not deeming an item (s) to
be applicable to them. Examples of reasons given are as
follows: “I am a widow and I don’t have sex anymore, so
I didn’t answer on the statement ‘I do not feel sexually
attractive’”; “I don’t own a car so I couldn’t answer the
question on having difficulty with driving”; “I couldn’t
answer the question ‘I have difficulty preparing meals’,
because my wife is the one that cooks at home, I never
do”. Outliers of 66 and 58 missing answers are found on
item 18 and 80. This was due to missing response cat-
egories in the first printed version of the questionnaire.
The mean number of missing answers on the Help-
items of the CARES was 12.4 (SD 21.5)-considerably
higher than the number of missing values on corre-
sponding QOL-items. Participants answered the Help-
questions by marking the response categories in three
different ways: by marking each ‘yes’ or ‘no’ for each
Help-question individually; by circling the words ‘yes’ or
‘no’ on the top of the column; or by circling the whole
column of yes-or no-responses on the page. Only 49
participants (27.8 %) had no missing answers on the
help-items (93–132 items). Both concurrent needs as-
sessment measures had a lower number of missing
values. For the one single help-question joining the DT
and PL only four participants (2.3 %) did not complete
the help-question. For the Care Needs Questionnaire
only four to 10 participants (2.3–5.7 %) did not complete
the life domain specific help-question.
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Table 1 Socio-demographic and medical characteristics participants and non-responders
Participants (N = 176) Non-responders (n = 122)a
M SD n % M SD n %
Socio-demographic Characteristics
Age 50.5 7.2 51.6 8.2
Sex
Men 54 30.7 38 31.1
Woman 122 69.3 83 68.0
Relational status
Single 20 11.4
Partner, married or living together 141 80.1
Partner, not married or living together 12 6.8
Widowed 3 1.7
Having children 148 84.1
Family members 11.9 10.8
Supportive family members 6.6 4.2
Supportive friends 13.5 12.6
Graduation level
Elementary school 13 7.4
High school 101 57.7









Monthly house hold income
< € 1500 51 30.7
€ 1500–€ 3000 79 47.6
> € 3000 36 21.7
Medical characteristics
Type of treatment
Surgery 138 81.7 94 84.7
Radiotherapy 104 61.2 52 46.8
Chemotherapy 109 64.5 57 51.8
Hormone therapy 58 34.3 27 24.3
Immune therapy 1 0.6 1 0.9
Concomitant radio-chemotherapy 18 10.7 16 14.4
Bone marrow transplantation 0 0.0 0 0.0
Isotopes 1 0.6 0 0.0
Other treatment 5 3.0 6 5.5
Time since diagnosis (weeks)b, c 62.8 104.5 − −
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Patients’ experiences in completing the CARES
On average participants needed 31 min (SD = 24.209) to
complete the CARES. Ninety percent felt this to be ac-
ceptable, 10 % thought this was too long and too time
consuming. Participants in this study had to complete
the CARES on paper. Seventy-three percent preferred
this option while 21 % would have preferred an elec-
tronic version. The reasons mentioned for preferring
paper were as follows: easier for concentration; limited
burden on the eyes; the ability to fill in anywhere; the
lack of familiarity with the computer. On the other hand,
reasons for preferring an electronic version for the com-
puter or tablet included environmental concerns, the
completion time of a screening and easier processing of
results.
Reliability
Internal consistency and test-retest reliability
To explore the reliability of the CARES total, sub- and
summary scales, alpha coefficients were calculated
(Table 2). The mean for all subscales was .79 (range
.21–.94). For the five summary scales of the CARES the
mean of alpha coefficients was .92 (range.87–.96).
The average timespan between the first and second
CARES completion of participants was 12.62 days (SD
9.3). Spearman’s rho correlations between the two com-
pletions were computed to explore test-retest reliability.
For all subscales high correlations were found ranging
from .53 to .89 with an average of .76. Test-retest corre-
lations for the five summary scales were all high, with an
average of .85 (Table 2). The CARES total scores had a
high correlation of .92. These reliability ratings demon-




The majority of participants rated all life domains ad-
dressed in the CARES to be important to very important
in a QOL and needs assessment tool (Table 3). Most of
them (90 %) evaluated the content of the CARES to be
complete. The three main areas where deficiencies were
cited were the feeling of loneliness in the disease experi-
ence, financial concerns due to the disease and
treatment and the lack of questions addressing the cop-
ing of patients’ loved ones.
Concurrent validity
Spearman rho correlations for CARES total, summary
scores and convergent measures were in the expected di-
rections (Additional file 1). The KPS and CARES phys-
ical scale have a large negative correlation (r = -.67).
HADS scores and the CARES psychosocial scale are
strongly positive related (r = .75 and r = .64). From the
SSL only the D-subscale had a significant moderate
correlation with the Psychosocial CARES summary scale
(r = .43). The Marital and Sexual CARES summary scales
are moderate to strongly positive related to the MMQ-
M (r = .48) respectively MMQ-S (r = .55). Also the large
correlations of the CARES Total score with the EORTC-
QLQ-C30 (r =−.56 and r =−.53) and DT (r = .63) confirm
the concurrent validity of the CARES.
Construct validity
There are intercorrelations of .32–.60 between CARES
summary scales, indicating that these measure related but
different dimensions of concerns and care needs. The
summary scales all have a high correlation with the CARES
Total, indicating an important role in the quality of life
disruption measured by the CARES (Additional file 1).
To ensure that the data were suitable for factor
analysis standard diagnostic tests were run each time.
Both the Kaiser-Meyer-Olkin (KMO) test of sampling
adequacy criterion (KMO ≥ .6) and Bartlett’s test of
sphericity criterion (p < .05) were fulfilled and indi-
cated factorability of the data.
Firstly, the CARES subscales were explored. For the
items of the physical summary scale six factors were
found. Medical interaction-items loaded on three factors,
psychosocial-items on nine, marital-items on four and
the items of the sexual summary scale on two factors
(Additional file 2).
Secondly, the summary scales were explored. Based on
Kaiser’s criterion (eigenvalue ≥1) seven factors were
distinguished with the PCA, explaining a total of 65.5 %
of the variance. However, based on Catell’s scree test,
only the first five factors should be retained to get a
good fitted model of factors explaining the variance in
Table 1 Socio-demographic and medical characteristics participants and non-responders (Continued)
Phase of care trajectory
Active treatment phase 115 65.3
Completion of treatment 13 7.4
Follow-up phase 47 26.9
Abbreviations: M mean, SD standard deviation, n number of participants
aData of only 117 out of 128 non-responders received, bDate of questionnaire completion or diagnosis missing for some participants, mean time since diagnosis
based on n = 158, cTime since diagnosis unknown for non-responders, since date of invitation to participate in the research was not registered
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our data set. Subsequently a PCA with varimax rotation
and fixed number of five factors was conducted resulting
in the factor solution visualized in Table 2. The resulting
factor solution approximately corresponds to the subdiv-
ision of the CARES in the five summary scales: physical,
interaction with the medical team, marital, psychosocial
and sexual.
Discussion
This study explored the validity of the Flemish CARES
version, resulting in a positive evaluation of the instrument.
The small number of missing answers on CARES’
QOL-items indicates that the items were clear to the
vast majority of participants, which supports the feasibil-
ity of the instrument for wider application or use among
Flemish cancer patients. Participants also reported
positive experiences with the content and completion
time of the CARES. The number of missing answers on
the Help-items of the CARES is relatively higher. The
question is raised whether if it is relevant to have a help-
question for each QOL-item. Possibly circling requires a
great effort of participants, resulting in a larger number
Table 2 Reliability ratings and factor pattern for the flemish CARES (N = 176)
Internal Consistency Test-Retest Correlation Factor loadingsb
Global CARES, sub-and summary scales α n ra Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
PHYSICAL .93 156 .90
Ambulation .83 158 .84 .749 .371
Activities of daily living .85 158 .83 .795
Recreational Activities .81 157 .73 .729
Weight Loss .74 157 .68 .733
Difficulty Working .93 152 .81 .728
Pain .71 156 .77 .430 .448 .369
Clothing .94 156 .76 .344 .347 .322
MEDICAL INTERACTION .87 156 .70
Problems Obtaining Info from Medical Team .85 156 .61 .836
Difficulty Communicating with Medical Team .86 157 .69 .540 .397
Control of Medical Team .77 157 .69 .776
MARITAL .90 133 .84
Communication with Partner .93 155 .82 .469 .636
Affection with partner .85 155 .74 .851
Interaction with Partner .88 155 .80 .705
Overprotection by Partner .56 155 .53 .313 .461
Neglect of Care by Partner .21 155 .63 .574 .326
PSYCHOSOCIAL .96 156 .91
Body Image .84 157 .80 .385 .549
Psychological Distress .86 157 .89 .302 .589 .466
Cognitive problems .89 157 .81 .429 .325 .413
Difficulty Communicating with friends/relatives .83 158 .77 .610
Friends/Relatives Difficulty Interacting .73 156 .65 .538 .324
Anxiety in Medical Situations .89 156 .86 .772
Worry .83 157 .84 .359 .664
Interaction with Children .78 155 .73 .330 .525
At Work Concerns .81 155 .67 .566
SEXUAL .92 142 .89
Sex Interest .82 156 .85 .460 .648
Sexual Dysfunction .92 154 .84 .533
CARES TOTAL .88 158 .92
aall r significant at 0.01 level (2-tailed), bOnly factor loadings≥ .30 are presented, factor loadings of facets belonging to each of the five CARES summary scales are in bold
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of missing answers, while domain specific help-
questions could be sufficient to reveal patients support-
ive care needs. The smaller number of missing answers
on the concurrent needs assessment instruments, may
indicate that a simplified help-questioning could be
more feasible. For example the 93–132 help-items could
be reduced to several life domain specific help-questions
presented each time after a group of QOL-items. Al-
though this aspect could use some improvement, the ma-
jority of the participants are in favor of the use of a QOL
and needs assessment tool like the CARES in clinical
practice.
The CARES provides a total score and five domain
specific scores, which all demonstrated high reliability.
The two subscales with low alpha coefficients ‘Overpro-
tection by Partner’ (α = .56) and ‘Neglect of care by
partner’ (α = .21) are scales with only two items. Having
fewer items in a scale is known to have a lowering effect
on the alpha coefficient. These reliability ratings corres-
pond to those of the original CARES.
The results of the PCA confirm the existence of five
distinguishable components of QOL measured with the
Flemish CARES, similar to the physical, medical inter-
action, relational, psychosocial and sexual summary scale
of the original instrument. However, some subscales
have double loadings. PCA should be reproduced as
soon as a larger research sample is available.
Concurrent validity of the CARES and its’ summary
scales with several instruments was confirmed with
moderate to high correlations. This implies that the
CARES could be used to obtain a comprehensive sum-
mary of patients’ overall QOL and care needs from their
own perspective instead of having to combine several
other patient reported outcome tools.
Limitations of this study should be noted. Rules-of-
thumb for the number of subjects included in factor
analysis vary from four to 10 subjects per item of the
questionnaire [32]. With 176 participants our research
sample is rather limited. However, the factor pattern of
the original instrument was already known and even
with our relatively small number of participants the ori-
ginal factor solution could be replicated. The CARES
was developed for cancer patients in general, though the
representativeness of our sample could be questioned.
To pursue representativeness, recruitment was per-
formed in several departments of the participating hos-
pitals. This resulted in a heterogeneous sample of 25–60
years aged cancer patients, with breast, colorectal, pros-
tate and head-neck cancer as most common cancer types.
This matches the national statistics [54], and characteris-
tics of our group of non-responders. Non-responders seem
to have undergone less invasive treatment (Table 1). How-
ever, there is a lack of further information, for example on
‘time since diagnosis’, to make a detailed comparison. The
Table 3 Participants’ evaluation of the content of the CARES (N = 159)
How important do you think several areas of well-being
are to be addressed in the CARES, when the purpose is to
comprehensively assess quality of life and care needs with
the instrument?
Response distributiona
Very important Important Not so important Totally not important
Physical well-being 90 (56.6 %) 62 (39.0 %) 2 (1.3 %) 0 (0.0 %)
Medical interaction 93 (58.5 %) 59 (37.1 %) 3 (1.9 %) 0 (0.00 %)
Relational well-being 82 (51.6 %) 59 (37.1 %) 7 (4.4 %) 1 (0.6 %)
Psychosocial well-being
Body image 31 (38.4 %) 82 (51.6 %) 12 (7.5 %) 0 (0.00 %)
Problems with memory and/or concentration 68 (42.8 %) 79 (49.7 %) 7 (4.4 %) 0 (0.00 %)
Stress, fear, concerns on disease and treatment 84 (52.8 %) 66 (41.5 %) 4 (2.5 %) 0 (0.00 %)
Dealing with family and friends 63 (39.6 %) 79 (49.7 %) 12 (7.5 %) 0 (0.00 %)
Dealing with the children 78 (49.1 %) 66 (41.5 %) 7 (4.4 %) 0 (0.00 %)
Concerns about work 53 (33.3 %) 77 (48.4 %) 19 (11.9 %) 3 (1.9 %)
Sexual interest and functioning 43 (27.0 %) 79 (49.7 %) 27 (17.0 %) 2 (1.3 %)
Miscellaneous
Financial difficulties 51 (32.1 %) 80 (50.3 %) 18 (11.3 %) 5 (3.1 %)
Finding a partner 22 (13.8 %) 52 (32.7 %) 37 (23.3 %) 27 (17.0 %)
Difficulties with regard to treatment 67 (42.1 %) 66 (41.5 %) 12 (7.5 %) 4 (2.5 %)
Was there a topic missing in the CARES that you find important in an assessment on psychosocial
concerns and care needs?
No Yes
132 (89.80 %) 15 (10.20 %)
aPercentages do not count up to 100 % due to missing values.
Schouten et al. BMC Cancer  (2016) 16:696 Page 9 of 11
selection of patients aged between 25–60 years to capture
the adult population of cancer patients, was an inherent
limitation as it limited the generalizability of results since
approximately three-quarters of cancers are diagnosed in
people aged over 60 years. The utility and validity of the
Flemish CARES should further be explored in patients
aged older than 60 years, before the instrument is imple-
mented in clinical practice.
While this study demonstrates rigor of the Flemish
CARES version across key psychometric properties, we
must acknowledge that other indices were not explored,
e.g. known groups comparison, predictive validity, re-
sponsiveness. Consequently, future studies that focus on
these aspects could strengthen the evidence of the valid-
ity of the Flemish CARES version.
Conclusions
This study confirms the Flemish CARES version to be a
comprehensive and feasible QOL and needs assessment
instrument with good psychometric properties. Conse-
quently, the Flemish CARES can be used in further re-
search to assess QOL and care needs. Further translational
research studies are needed to explore how the use of such
a tool can be implemented efficiently in clinical practice to
contribute to quality patient-centered care.
Additional files
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